The new Histocompatibility and Immunogenetics Laboratory launched its first phase of testing June 26 and ultimately will fully support clinical testing for the Vanderbilt Transplant Center, the nation’s third busiest transplant center by volume.

Phone call changes the life of family whose daughter with cystic fibrosis needed both a liver and pancreas transplant.

Pinson, who is stepping away from his role as Deputy CEO and Chief Health System Office for VUMC on June 30, was a pioneer in the field of liver transplantation, founding the Vanderbilt Liver Transplant Program and establishing multiple transplant residency and nurse practitioner programs.

She was turned down by multiple transplant centers between Honolulu and Nashville, deemed too sick, before the Vanderbilt Lung Transplant Program accepted her as a patient.

The OPTN is a unique public-private partnership that links all professionals involved in the U.S. donation and transplantation system.

O’Dell succeeds Edward Zavala, MBA, the VTC’s founding administrator who is stepping down from his administrative leadership role June 30 after more than 22 years of service to VUMC.  

As a world leader in advanced cardiac care and organ transplantation, VUMC is committed to raising awareness and educating the public about the lifesaving impact of organ donation.